Medtronic plc Stock

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-05-06 pm EDT 5-day change 1st Jan Change
81.76 USD +0.09% Intraday chart for Medtronic plc +1.11% -0.75%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 32.24B Sales 2025 * 33.57B Capitalization 108B
Net income 2024 * 4.56B Net income 2025 * 5.24B EV / Sales 2024 * 4.05 x
Net Debt 2024 * 22.21B Net Debt 2025 * 21.12B EV / Sales 2025 * 3.86 x
P/E ratio 2024 *
23.3 x
P/E ratio 2025 *
20.2 x
Employees 95,000
Yield 2024 *
3.37%
Yield 2025 *
3.54%
Free-Float 99.82%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Medtronic plc

1 day+0.09%
1 week+1.11%
Current month+1.89%
1 month-3.31%
3 months-6.82%
6 months+11.36%
Current year-0.75%
More quotes
1 week
79.99
Extreme 79.99
82.56
1 month
78.43
Extreme 78.43
84.35
Current year
78.43
Extreme 78.43
89.18
1 year
68.84
Extreme 68.84
91.00
3 years
68.84
Extreme 68.84
135.89
5 years
68.84
Extreme 68.84
135.89
10 years
55.54
Extreme 55.54
135.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 15-01-25
Director of Finance/CFO 58 16-05-31
Chief Operating Officer 63 21-03-31
Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 70 06-12-31
Director/Board Member 68 14-12-31
More insiders
Date Price Change Volume
24-05-06 81.76 +0.09% 3,611,492
24-05-03 81.69 +0.95% 4,987,236
24-05-02 80.92 +0.04% 6,338,796
24-05-01 80.89 +0.81% 5,366,116
24-04-30 80.24 -0.77% 6,487,413

Delayed Quote Nyse, May 06, 2024 at 04:00 pm EDT

More quotes
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
81.69 USD
Average target price
94.77 USD
Spread / Average Target
+16.02%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW